Company: CERO
Filing Date: 2025-08-15
Form Type: NT 10-Q
Source: 0001213900-25-077436
Chunk: 5

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-15
Form: NT 10-Q
Chunk 5
---
 management’s beliefs, expectations, or opinions
should change, except as required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place
undue reliance on, forward-looking statements.

<div align='center'>3

CERo Therapeutics Holdings, Inc.

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

| Date: August 15, 2025 | By: | /s/ Andrew Kucharchuk |                         |
|:----------------------|:----|:----------------------|:------------------------|
|                       |     | Name:                 | Andrew Kucharchuk       |
|                       |     | Title:                | Chief Financial Officer |

<div align='center'>4</div>